The immunohistochemistry test detects the folate receptor 1 protein, which is over-expressed in most ovarian cancers.

CNW/ - Hoffmann-La Roche Limited (Roche Canada) is pleased to announce, with support from the Government of Ontario through ...

Roche has secured CE mark approval for its immunohistochemistry (IHC) companion diagnostic test, VENTANA FOLR1 (FOLR1-2.1) ...

The global cardiac biomarker diagnostic test kits market is poised for significant growth, with an estimated market size of ...

Roche (RHHBY) announced that it has received CE Mark for its Ventana FOLR1 RxDx Assay. This is the first immunohistochemistry, or IHC, ...

Initiative aims to strengthen diagnostic capabilities in the public sector, providing Kenyan patients with access to ...